BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7907291)

  • 1. CD8+ cytolytic T lymphocytes become infected in vitro in the process of killing HIV-1-infected target cells.
    De Maria A; Colombini S; Schnittman SM; Moretta L
    Eur J Immunol; 1994 Mar; 24(3):531-6. PubMed ID: 7907291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection of CD8+ T lymphocytes with HIV. Requirement for interaction with infected CD4+ cells and induction of infectious virus from chronically infected CD8+ cells.
    De Maria A; Pantaleo G; Schnittman SM; Greenhouse JJ; Baseler M; Orenstein JM; Fauci AS
    J Immunol; 1991 Apr; 146(7):2220-6. PubMed ID: 1706390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of antigen expression kinetics on the effectiveness of HIV-specific cytotoxic T lymphocytes.
    van Baalen CA; Guillon C; van Baalen M; Verschuren EJ; Boers PH; Osterhaus AD; Gruters RA
    Eur J Immunol; 2002 Sep; 32(9):2644-52. PubMed ID: 12207349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple subsets of HIV-specific cytotoxic T lymphocytes in humans and in mice.
    Chenciner N; Michel F; Dadaglio G; Langlade-Demoyen P; Hoffenbach A; Leroux A; Garcia-Pons F; Rautmann G; Guy B; Guillon JM
    Eur J Immunol; 1989 Sep; 19(9):1537-44. PubMed ID: 2676560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary proliferative and cytotoxic T-cell responses to HIV induced in vitro by human dendritic cells.
    Macatonia SE; Patterson S; Knight SC
    Immunology; 1991 Nov; 74(3):399-406. PubMed ID: 1769689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection.
    Borghan MA; Oka S; Takiguchi M
    Tissue Antigens; 2005 Oct; 66(4):305-13. PubMed ID: 16185326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated peripheral CD8 lymphocytes express CD4 in vivo and are targets for infection by human immunodeficiency virus type 1.
    Imlach S; McBreen S; Shirafuji T; Leen C; Bell JE; Simmonds P
    J Virol; 2001 Dec; 75(23):11555-64. PubMed ID: 11689637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-infected humans, but not chimpanzees, have circulating cytotoxic T lymphocytes that lyse uninfected CD4+ cells.
    Zarling JM; Ledbetter JA; Sias J; Fultz P; Eichberg J; Gjerset G; Moran PA
    J Immunol; 1990 Apr; 144(8):2992-8. PubMed ID: 1969880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes.
    Collins KL; Chen BK; Kalams SA; Walker BD; Baltimore D
    Nature; 1998 Jan; 391(6665):397-401. PubMed ID: 9450757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective in vitro expansion of HLA class I-restricted HIV-1 Gag-specific CD8+ T cells: cytotoxic T-lymphocyte epitopes and precursor frequencies.
    van Baalen CA; Klein MR; Geretti AM; Keet RI; Miedema F; van Els CA; Osterhaus AD
    AIDS; 1993 Jun; 7(6):781-6. PubMed ID: 7689847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-CD4 cytotoxic T lymphocyte (CTL) activity in HIV+ patients: flow cytometric analysis.
    Yamamura Y; Rodriguez N; Schwartz A; Eylar E; Yano N
    Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S133-44. PubMed ID: 8574141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Equivalent recognition of HIV proteins, Env, Gag and Pol, by CD4+ and CD8+ cytotoxic T-lymphocytes.
    Kundu SK; Merigan TC
    AIDS; 1992 Jul; 6(7):643-9. PubMed ID: 1354446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens.
    Ho HN; Hultin LE; Mitsuyasu RT; Matud JL; Hausner MA; Bockstoce D; Chou CC; O'Rourke S; Taylor JM; Giorgi JV
    J Immunol; 1993 Apr; 150(7):3070-9. PubMed ID: 8454874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual function of a human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte clone: inhibition of HIV replication by noncytolytic mechanisms and lysis of HIV-infected CD4+ cells.
    Buseyne F; Février M; Garcia S; Gougeon ML; Rivière Y
    Virology; 1996 Nov; 225(1):248-53. PubMed ID: 8918556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloned human CD4+ cytotoxic T lymphocytes specific for Toxoplasma gondii lyse tachyzoite-infected target cells.
    Curiel TJ; Krug EC; Purner MB; Poignard P; Berens RL
    J Immunol; 1993 Aug; 151(4):2024-31. PubMed ID: 8102155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients.
    Langlade-Demoyen P; Ngo-Giang-Huong N; Ferchal F; Oksenhendler E
    J Clin Invest; 1994 Mar; 93(3):1293-7. PubMed ID: 8132769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of HIV-1-specific cytotoxic T lymphocytes expressing the mucosal lymphocyte integrin CD103 in rectal and duodenal lymphoid tissue of HIV-1-infected subjects.
    Shacklett BL; Beadle TJ; Pacheco PA; Grendell JH; Haslett PA; King AS; Ogg GS; Basuk PM; Nixon DF
    Virology; 2000 May; 270(2):317-27. PubMed ID: 10792991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human cytotoxic T lymphocytes. III. Large numbers of peripheral blood T cells clonally develop into allorestricted anti-viral cytotoxic T cell populations in vitro.
    Kabelitz D; Herzog WR; Heeg K; Wagner H; Reimann J
    J Mol Cell Immunol; 1987; 3(1):49-60. PubMed ID: 2855406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1-specific CTL responses primed in vitro by blood-derived dendritic cells and Th1-biasing cytokines.
    Wilson CC; Olson WC; Tuting T; Rinaldo CR; Lotze MT; Storkus WJ
    J Immunol; 1999 Mar; 162(5):3070-8. PubMed ID: 10072560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific CD8(+) T-lymphocytes control dissemination of measles virus.
    de Vries RD; Yüksel S; Osterhaus AD; de Swart RL
    Eur J Immunol; 2010 Feb; 40(2):388-95. PubMed ID: 19950186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.